Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT138711111617N1Phase 3Completed
Phase 3, randomised, double-blind trial in cough comparing Intracuff lidocaine 2% alone with Intracuff lidocaine 2% plus dexamethasone (2 arms). Primary endpoint: Reduction in post-anesthesia respiratory complications. Started Jun 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT138711111617N1.